
Ingenieur, Abenteurer und Kämpfer gegen chronische Krankheiten 💪 #MECFS
Cologne
Joined May 2023
- Tweets2.5K
- Following230
- Followers64
- Likes6.3K
Maximilian Bauer retweeted
FDA Approves Giredestrant + Everolimus for ESR1-Mutated, ER+/HER2− Advanced Breast Cancer:
evERA Shows a 62% Reduction in the Risk of Progression or Death (HR 0.38), While OS Benefit Is Not Yet Established.
#BreastCancer @OncoAlert #Bcsm
fda.gov/drugs/cancer-approva…
Maximilian Bauer retweeted
8/ My practice: DOAC for nearly everyone. Fix modifiable bleeding risk first.
LAAC: a true, nonreversible OAC contraindication, case by case, with real SDM.
Don't read it as: "LAAC is noninferior to a DOAC." Read it as: different risks, unproven stroke protection.
Maximilian Bauer retweeted
Starting today, masks are required in all NIH Clinical Center patient care areas. 😷👍
Maximilian Bauer retweeted
Membership shouldn’t just be something you have. It should be something you use.
Throughout the year, ISN membership connects you to education, scientific content, professional opportunities, events, and colleagues around the world.
Your next opportunity might be a course. A paper. A grant. A fellowship. A connection. A congress. Or something you haven’t discovered yet.
🌍 One membership. A year of possibilities.
🔗 Explore ISN’s lower membership fees and join our global kidney health community in 2027: bit.ly/3TzOWP3
Maximilian Bauer retweeted
My trainer has me taking it up a notch. Push a little more. Eat a little more. Crawling my way to 92kg. It’s a slow climb from 89kg 18 months ago. It’s never overnight. Get fit if you can!
Maximilian Bauer retweeted
Amazing #grosspath pic by my friend Dr. Nejib Ben Yahia (Twitter: @NejibY). He takes some of the best gross photos in the world! What is the diagnosis?
Answer: kikoxp.com/posts/20984
#pathologists #pathology #pedipath #pathTwitter #MedTwitter #MedStudentTwitter #usmle
Maximilian Bauer retweeted
What does "Amyloid Mafia" mean? Charles Piller explains the phrase.
Full episode: youtu.be/K9qEx98D2Ww
#Alzheimers #ResearchIntegrity #HealthLongevitySecrets
Maximilian Bauer retweeted
Meet our group member Siting Li!
Siting is PhD Student @i3S_UPorto, and Master from Zhengzhou University, China. She is currently working on translational colorectal cancer nanomedicines. Find more about her work at i3s.up.pt/personal-info.php?…
Maximilian Bauer retweeted
⭐ New Editor's Choice Article!
📖 Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery🎯
💡 Curious about the results? 👇
🔗 mdpi.com/1999-4923/17/10/135…
#Pharmaceutics #PCL #PLA #PLGA #Anticancer #DrugDelivery #EditorsChoice #OpenAccess
Maximilian Bauer retweeted
Falls das überhaupt noch jemanden interessiert:
Es wurde ein neues #WissZeitVG beschlossen.
Jetzt wird bestimmt alles besser!
#IchBinHanna und so...
bmftr.bund.de/SharedDocs/Kur…
Maximilian Bauer retweeted
📢 Deadline Extended – Special Issue in Pharmaceutics
The submission deadline for the Special Issue "Biomaterials: Pharmaceutical Applications” has been extended to 30 June 2027! 💊
🔬 Guest Editor: Dr. Claudia Garnero
🔗brnw.ch/21x76ky
Maximilian Bauer retweeted
🧬 In phase III HEALER, anbenitamab + HB1801 improved 24-month PFS rates vs THP in HER2+ advanced #BreastCancer (58.5% vs 34.4%).
➡️ Grade ≥3 adverse events were higher (45.9% vs 34.4%). OS data are immature.
▪️ Binghe Xu, MD, PhD | @NEJM | #ESMO26
🔗 ascopost.com/news/november-2…
Maximilian Bauer retweeted
Deutschlands Gasspeicher sind nur zu 58 Prozent gefüllt. Bei Extremkälte droht ab Januar Gasmangel. Reiche bereitet deshalb Kohle- und Ölkraftwerke vor. berliner-zeitung.de/article/…
Maximilian Bauer retweeted
Excited to share ChronicleBio’s first clinical trial partnership, with Prolong Pharmaceuticals, evaluating PP-007 (Sanguinate) for post-exertional malaise in ME/CFS.
Heterogeneous diseases need this approach.
Today we are announcing our first clinical trial. We're joining forces with Prolong to evaluate a potential treatment for post exertional malaise (PEM) in #MECFS.
Sanguinate is an investigational intravenous therapy designed to deliver oxygen to deprived tissues, support blood flow, and reduce inflammation. The planned multi-site Phase 2a trial will evaluate the drug in at least 40 patients with first dosing expected mid-2027.
Most trials enroll patients based on symptoms alone, but recruitment for this study will leverage ChronicleBio's proprietary endotype intelligence platform to identify patients whose disease biology suggests they may be more likely to respond.
We are excited for our partnership with Prolong and grateful for the patient community that drives everything we do.
Read More: chroniclebio.com/news/chroni…
Maximilian Bauer retweeted
500 Athlete Signatures 🤩⭐️🏅
We’ve had so much interest since our initial athlete letter to the Prime Minister that we’ve now sent a second letter, this time with 500 athletes backing my call to meet with me and fund ME properly (prev 360).
Huge names including David Moyes (we know Andy’s an Everton fan 👀), Millie Bright & so many stars from a variety of sports 🙏🏼 I can’t tell you how grateful I am to every single one of you!!
Please @andyburnham , take an illness that’s been neglected more than almost anything else seriously 🙏🏼 1.35m people in the country estimated to be impacted, that’s a lot of the vote share!! @UKLabour
I know I owe lots of people replies and thanks, please bear with me and thank you so much again ❤️❤️❤️
Maximilian Bauer retweeted
What does the future of AI-enabled pathology look like? Daljeet Bansal (NPIC Director of Operations, Leeds Teaching Hospitals NHS) explores digital pathology, smarter workflows and precision diagnostics at FOG London.
Register here: hubs.la/Q04Czkj90
#FOG2027 #DigitalPathology #AI
Maximilian Bauer retweeted
In this research evidence is provided that during neurodegeneration promoted by methamphetamine endogenous expression of heat shock proteins is induced to counteract cell death. 🔬This occurs to empower cell clearing pathways.
mdpi.com/2227-9059/14/9/2134
Maximilian Bauer retweeted
When a scientist sends an experiment to Nebula, Ginkgo’s autonomous lab at our HQ in Boston, it doesn’t wait in line. Our agent “interleaves” it with everything already running, so many experiments can share the same robots without getting in each other’s way.
In this video we show it three ways: a live Gantt chart where each row is a robotic cart and each color is an experiment, a subway-style track map where levitating “pucks” carry samples between carts, and robot-cam footage that follows one experiment from start to finish.
The schedule is never set in stone. Nebula is constantly replanning, and the Gantt chart shows every change as it happens.
You can see it for yourself. Book a free tour: calendly.com/ginkgo-bio/tour…
Maximilian Bauer retweeted
🌟#CallforPapers🌟
📚Nuclear Control of Cell Death: Physiology and Disease
👨🔬Guest Editor: Prof. Dr. Nan-Shan Chang
👨🔬Guest Editor Assistant: Dr. Hieu-Huy Nguyen-Tran
🔗 Find Out More: mdpi.com/journal/ijms/specia…
⏰Submission Deadline: 31 May 2027
#OpenAccess #MDPIIJMS
Combining Empirical and Computational Techniques to Detect and Prevent Cancer—
Kathleen Curtius and Kornelia Polyak will address this topic in an AACR Cancer Evolution Working Group Webinar moderated by E. Shelley Hwang (Dec 8, 11:30AM-1PM ET).
brnw.ch/21x73gi
@LabPolyak





































